多粘菌素

Polymyxin B is a potent antibiotic used to treat severe bacterial infections, particularly in burn wounds and cystic fibrosis patients.
克拉霉素B是一种强大的抗生素，用于治疗严重的细菌感染，特别是在烧伤患者和囊性纤维化患者中。
The combination of gentamicin and polymyxin E showed synergistic effects against multidrug-resistant bacteria.
替加米星和多黏菌素E的联合使用对多重耐药细菌显示出协同作用。
In veterinary medicine, polymyxin is used as an ophthalmic solution to treat bacterial eye infections in animals.
在兽医学中，多黏菌素被用作眼科溶液，用于治疗动物的眼部细菌感染。
Due to its broad-spectrum activity, polymyxin has been considered for inclusion in the treatment of atypical pneumonia caused by certain bacteria.
由于其广谱活性，多黏菌素被考虑用于治疗某些细菌引起的非典型肺炎的治疗。
Unfortunately, the widespread misuse of polymyxin has led to the emergence of resistant strains, posing a significant challenge to healthcare.
不幸的是，多黏菌素的滥用导致了耐药菌株的出现，给医疗保健带来了重大挑战。
The researchers discovered a new mechanism by which polymyxin can combat drug-resistant bacteria, offering hope for more effective treatments.
研究人员发现了一种新的多黏菌素对抗耐药细菌的机制，为更有效的治疗提供了希望。
In the era of antibiotic resistance, polymyxin is being revisited as a potential last-line therapy for some life-threatening infections.
在抗生素抵抗的时代，多黏菌素正在重新被审视，作为一种可能的二线疗法来治疗某些威胁生命的感染。
Despite its side effects, such as nephrotoxicity, polymyxin remains a valuable weapon in the fight against gram-negative superbugs.
尽管存在肾毒性等副作用，多黏菌素仍然是对抗革兰阴性超级细菌的重要武器。
Polymyxin therapy requires close monitoring due to its potential for serious adverse reactions, especially in critically ill patients.
因为多黏菌素有可能引发严重副作用，因此治疗时需要密切监测，尤其是对于危重病人。
Future research will focus on developing safer alternatives to polymyxin or improving its delivery methods to minimize its risks while maximizing its benefits.
未来的研究将集中在开发多黏菌素的更安全替代品或改进其给药方式，以最小化风险并最大化其效益。